Skip to contentS
Selectis Health, Inc.
S
GBCSSelectis Health, Inc. Q3 2020 · 10-Q
Revenue$6.32M$6.32M+217.7% vs Q3 2019 Net Income$466.68K$466.68K+153.5% vs Q3 2019 EPS Diluted$0.15$0.15+1,400.0% vs Q3 2019 Operating Income$986,954+55.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Selectis Health, Inc. · CIK 727346 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$865,176N/M Margins · derivedOperating margin15.6%−16.3 pt vs Q3 2019
Net margin7.4%−1.9 pt vs Q3 2019
ended Sep 30, 2020 · filed Dec 31, 2020 · 92 d after period end